Commitments (Details)	6 Months Ended
	Dec. 31, 2020 USD ($) $ / shares
Disclosure Text Block Supplement [Abstract]
Deferred fee per unit price (in Dollars per share) | $ / shares	$ 0.35
Deferred fee amount	$ 16,100,000
Agreement, description	Pursuant to the Merger Agreement, the aggregate merger consideration payable to the stockholders of HydraFacial will be paid in a combination of stock and cash equal to $975,000,000, subject to adjustments, (the “Merger Consideration”). The cash consideration will be an amount equal to the Company’s cash and cash equivalents as of the Closing (including proceeds in connection with the Private Placement and the funds in the Company’s Trust Account), minus HydraFacial’s outstanding indebtedness at the closing, minus transaction expenses of HydraFacial and the Company, minus $100,000,000. However, cash consideration, together with certain contractual fee payments, will be subject to a maximum of 60% of the aggregate Merger Consideration. The remainder of the Merger Consideration will be paid in a number of shares of newly issued Class A common stock of the Company (“Company Common Stock”) valued at $10.00 per share.
Payment of common stock	$ 75,000,000